Co-Diagnostics Reports Fourth-Quarter and Full-Year 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Co-Diagnostics (CODX) Misses Q4 EPS by 5c, Revenues Beat
March 25, 2021 4:03 PM EDTCo-Diagnostics (NASDAQ: CODX) reported Q4 EPS of $0.43, $0.05 worse than the analyst estimate of $0.48. Revenue for the quarter came in at $27.1 million versus the consensus estimate of $24.99 million.
Fourth Quarter 2020 Financial Results:
Revenue of $27.1 million, primarily due to sales of the Logix Smart COVID-19 TestGross profit increased to $22.8 million, representing 84.1% of consolidated revenue due to improved product mix as compared... More